RNA vs GOOGL: Which Stock is Better?

Side-by-side comparison of Atrium Therapeutics, Inc. Common Stock and Alphabet Inc Class A in 2026

Comparison Updated:

RNA

Atrium Therapeutics, Inc. Common Stock

$13.80

GOOGL

Alphabet Inc Class A

$337.34

Key Metrics Comparison

MetricRNAGOOGLWinner
Market Cap$217.50M$2.97TGOOGL
P/E RatioN/A32.79RNA
EPS (TTM)$N/A$10.12GOOGL
Revenue Growth14.0%15.9%GOOGL
Gross Margin0.0%59.7%GOOGL

Analyze RNA

Full quant analysis

Analyze GOOGL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is RNA or GOOGL a better investment?

Comparing RNA and GOOGL: Atrium Therapeutics, Inc. Common Stock has a market cap of $217.50M while Alphabet Inc Class A has $2.97T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between RNA and GOOGL?

RNA (Atrium Therapeutics, Inc. Common Stock) and GOOGL (Alphabet Inc Class A) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: RNA or GOOGL?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: RNA or GOOGL?

GOOGL has higher revenue growth at 15.9% vs 14.0% for RNA.

Which company is more profitable: RNA or GOOGL?

Alphabet Inc Class A (GOOGL) has higher gross margins at 59.7% compared to 0.0% for RNA.

Which is the larger company: RNA or GOOGL?

Alphabet Inc Class A (GOOGL) is larger with a market cap of $2.97T compared to $217.50M for RNA.

Should I buy RNA or GOOGL in 2026?

Both RNA and GOOGL have investment merit. RNA trades at $13.80 while GOOGL trades at $337.34. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between RNA and GOOGL stock?

Key differences: Market Cap ($217.50M vs $2.97T), P/E Ratio (N/A vs 32.8x), Revenue Growth (14.0% vs 15.9%), Gross Margin (0.0% vs 59.7%).

Should I buy RNA or GOOGL in 2026?

The choice between RNA and GOOGL depends on your investment goals. GOOGL shows higher revenue growth (15.9%). GOOGL has better margins (59.7%). Consider your risk tolerance and time horizon.

What is the market cap comparison between RNA and GOOGL?

RNA (Atrium Therapeutics, Inc. Common Stock) has a market cap of $217.50M, while GOOGL (Alphabet Inc Class A) has a market cap of $2.97T. GOOGL is the larger company by market value.

Popular Stock Comparisons